Matthew Sirovich
CIK 1431208 · last filed 2020-11-27
Matthew Sirovich is a corporate insider who has filed 29 SEC Form 4 insider transactions across 6 companies since 2008. The most recent filing shows the insider sold $170.9K of PAVMZ on Nov 27, 2020. Across all open-market trades the lifetime net is −$44.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $559.6M across reported positions. 109 SEC filings were submitted jointly with Jeremy Mindich.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
ACOR price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
450 SEVENTH AVENUE, 43RD FLOOR
NEW YORK, NY 10123
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PAVmed Inc. (PAVMZ) Delisted | 10%+ Owner | 2,966,041 | $0.00 | $2.7K | -$755.6K | 5 | 2020-11-27 |
| ITRI | 10%+ Owner | 4,878,384 | $87.65 | $427.59M | $45.05M | 11 | 2019-05-23 |
| Acorda Therapeutics, Inc. (ACOR) Delisted | 10%+ Owner | 42,826 | $0.66 | $28.3K | -$89.77M | 10 | 2019-01-11 |
| Barzel Industries Inc. (TONSW) Delisted | 10%+ Owner | 2,573,409 | — | — | $5.5K | 1 | 2008-10-03 |
| CENT | 10%+ Owner | 2,909,080 | $45.38 | $132.01M | $437.4K | 1 | 2008-04-23 |
| SOURCE INTERLINK COMPANIES INC (SORC) Delisted | 10%+ Owner | 5,421,076 | — | — | $963.7K | 1 | 2008-04-02 |
Recent Filings
29 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-11-27 | PAVmed Inc. (PAVMZ) Delisted | Sell (S) | −86,239 | -$170.9K | EDGAR |
| 2020-11-20 | PAVmed Inc. (PAVMZ) Delisted | Sell (S) | −100,000 | -$181.6K | EDGAR |
| 2020-06-01 | PAVmed Inc. (PAVMZ) Delisted | Sell (S) | −200,921 | -$403.1K | EDGAR |
| 2020-02-03 | PAVmed Inc. (PAVMZ) Delisted | Exer (X) | +1,199,383 | $12.0K | EDGAR |
| 2019-05-23 | ITRI | — | — | $0 | EDGAR |
| 2019-03-13 | ITRI | Mixed | −837,400 | -$12.34M | EDGAR |
| 2019-01-28 | PAVmed Inc. (PAVMZ) Delisted | Other (J) | +332,400 | $0 | EDGAR |
| 2019-01-11 | Acorda Therapeutics, Inc. (ACOR) Delisted | Sell (S) | −649,964 | -$11.17M | EDGAR |
| 2018-12-26 | Acorda Therapeutics, Inc. (ACOR) Delisted | Sell (S) | −162,024 | -$2.14M | EDGAR |
| 2018-12-13 | Acorda Therapeutics, Inc. (ACOR) Delisted | Sell (S) | −1,200,000 | -$19.56M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.